Sigmoidoscopy: a shortcut to effective screening or a dead end?

Affiliations

¹ Department of Gastroenterological Oncology and Department of Cancer Prevention, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.
² Department of Gastroenterological Oncology and Department of Cancer Prevention, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway. Electronic address: mfkaminski@coi.waw.pl.

Comment

Marek Bugajski et al. Lancet Gastroenterol Hepatol. 2019 Feb.

. 2019 Feb;4(2):82-83.

doi: 10.1016/S2468-1253(18)30410-2. Epub 2018 Nov 29.

¹ Department of Gastroenterological Oncology and Department of Cancer Prevention, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.
² Department of Gastroenterological Oncology and Department of Cancer Prevention, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway. Electronic address: mfkaminski@coi.waw.pl.

No abstract available

Comment on

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA, Pinsky PF, Schoen RE, Prorok PC, Church TR. Miller EA, et al. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):101-110. doi: 10.1016/S2468-1253(18)30358-3. Epub 2018 Nov 29. Lancet Gastroenterol Hepatol. 2019. PMID: 30502933 Free PMC article. Clinical Trial.